title: Second malignancies in chronic lymphocytic leukemia.
authors.affiliation: Cancer Care Manitoba, Winnipeg, Manitoba, Canada.
authors.forename: Erin
authors.initials: E
authors.lastname: Streu
mesh_terms: D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D002280:Basal Cell Carcinoma / Q000209:etiology* / Q000601:surgery; D002294:Carcinoma, Squamous Cell / Q000209:etiology* / Q000532:radiotherapy / Q000556:secondary / Q000601:surgery; D002699:Chlorambucil / Q000009:adverse effects / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004428:Ear Neoplasms / Q000209:etiology / Q000532:radiotherapy / Q000601:surgery; D042241:Early Diagnosis; D006801:Humans; D016867:Immunocompromised Host; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy* / Q000276:immunology / Q000451:nursing; D017254:Leukemic Infiltration; D008297:Male; D016609:Neoplasms, Second Primary / Q000139:chemically induced / Q000453:epidemiology / Q000209:etiology* / Q000276:immunology / Q000451:nursing; D012306:Risk; D000069283:Rituximab; D012867:Skin / Q000473:pathology; D012878:Skin Neoplasms / Q000209:etiology* / Q000601:surgery; D014740:Vidarabine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D002699:Chlorambucil; D000069283:Rituximab; D014740:Vidarabine; C024352:fludarabine
keywords: ambulatory care; clinical practice; hematology; late effects; leukemia; lymphoma